News from Atom Bioscience

Atom Bioscience Receives FDA IND Clearance for Clinical Trial of ABP-745 for Acute Gout
PRESS RELEASE Atom Bioscience Receives FDA IND Clearance for Clinical Trial of ABP-745 for Acute Gout JIANGSU,...
Atom Bioscience Raises $83M in a D-Round Financing to Support Global Pivotal Clinical Trials of ABP-671, a New Treatment for Chronic Gout
PRESS RELEASE Atom Bioscience Raises $83M in a D-Round Financing to Support Global Pivotal Clinical Trials...
Atom Bioscience Doses First Patient in Phase 2b/3 Clinical Trial of a New Treatment for Chronic Gout
PRESS RELEASE Atom Bioscience Doses First Patient in Phase 2b/3 Clinical Trial of a New Treatment for...
Atom Bioscience Marks Gout Awareness Day by Urging Increased Patient Education on Debilitating Effects of the Chronic Disease
PRESS RELEASE Atom Bioscience Marks Gout Awareness Day by Urging Increased Patient Education on Debilitating...
Atom Bioscience Names UC San Diego Professor Robert Terkeltaub, M.D., to its Scientific Advisory Board
PRESS RELEASE Atom Bioscience Names UC San Diego Professor Robert Terkeltaub, M.D., to its Scientific...
Atom Bioscience Announces Positive Results of Phase 2a China Clinical Trial of Its URAT1 Inhibitor for Chronic Gout
PRESS RELEASE Atom Bioscience Announces Positive Results of Phase 2a China Clinical Trial of Its URAT1...
Atom Bioscience to Present at BIO CEO & Investor Conference on February 6, 2023, at the Marriott Marquis, New York City
PRESS RELEASE Atom Bioscience to Present at BIO CEO & Investor Conference on February 6, 2023, at...
Atom Bioscience Names Stanford University Professor Vibeke Strand, M.D., to its Scientific Advisory Board
PRESS RELEASE Atom Bioscience Names Stanford University Professor Vibeke Strand, M.D., to its Scientific...
Atom Bioscience to Present Final Data from its Positive Phase 2a Clinical Trial in Chronic Gout at American College of Rheumatology Annual Meeting, Nov. 10 – 14, in Philadelphia, PA
PRESS RELEASE Atom Bioscience to Present Final Data from its Positive Phase 2a Clinical Trial in Chronic...
Atom Bioscience Announces Abstract for Its Phase 2a Gout Study Accepted for American College of Rheumatology Annual Meeting, Nov. 10 – 14, in Philadelphia
PRESS RELEASE Atom Bioscience Announces Abstract for Its Phase 2a Gout Study Accepted for American College...

Atom Bioscience in the News

Pipeline Review: Atom Bioscience Receives FDA IND Clearance for Clinical Trial of ABP-745 for Acute Gout
Endpoints: Atom Bioscience raises $83M in Series D for URAT1 inhibitor in chronic gout treatment
BioSpace: Atom Bioscience Doses First Patient in Phase 2b/3 Clinical Trial of a New Treatment for Chronic Gout
Fierce Biotech: Atom Bioscience Hopes to Make Big Bang with New Gout Awareness Campaign
Practical Pain Management: Gout Myths -- Busted
BioWorld: Atom Bioscience Planning Phase III Gout Trial After Encouraging Mid-Stage Readout
BioSpace: Atom Bioscience Announces Positive Phase 2a Results For Investigational New Drug to Treat Chronic Gout

Industry News

HCPLive.com: Real-World Study Reveals Poor Disease Control in Adults with Gout
HCPLive.com: Study Explores the Patient Perspective of Gout Remission
HCPLive.com: Patients with Gout More Likely to Experience Stroke, Heart Failure
Docwirenews: Serum Uric Acid Levels in Patients with Gout
AJMC: The Connection Between Gout and CVD Requires Cross-Specialty Collaboration
Docwirenews: Gout Associate with Increased CVD and Heart Failure Risk in Black Population
Renal & Urology News: Hyperuricemia, Gout Increase Heart Failure, Death Risk
Practical Pain Management: How can I get my patients to understand that gout is a chronic disease?
WebMD: The Link Between Gout and Depression - What to Know
Docwirenews: Study Reveals High CVD Risk in Gout Patients
Contemporary OBGYN: Exploring the gender differences of comorbidities in patients with gout
HCP Live: Mortality Risk in Gout Has Persisted for Decades Despite Advances in Care
News-Medical.net: Gout unveiled as surprising culprit in neurodegenerative diseases
Renal & Urology News: Gout Burden Increasing Among Asians in the United States
Healio: Well-controlled serum urate levels in gout result in lower fracture risk
Clinical Trials Arena: Atom Bioscience reports positive Phase IIa chronic gout therapy trial data
Rheumatology Advisor: National Kidney Month Spotlight: Uric Acid and Its Role in Chronic Kidney Disease
HCPLive: Gout Isn’t a Punchline. It’s Time to Stop Treating it Like One
Physicians Weekly: ULT for Gout Leads to Long-Term Reduction in Hospitalization Risk
The Irish News: Why a gout pill could cut high blood pressure - and boost your sex life
Kidney Disease Among Top Contributors to Excess Death Risk in Veterans With Gout
Renal & Urology News: Kidney Disease Among Top Contributors to Excess Death Risk in Veterans With Gout
News-Medical.net: Gout: Disease of Kings now a 21st Century Epidemic
News-Medical.net: Study finds a novel therapeutic target for prevention and treatment of gout
DocWireNews: Depression and Anxiety in Patients After Gout Diagnosis
Arthritis & Rheumatology: Study Compares Gout Treatments with Different Mechanisms of Action - URAT1 Inhibitor vs Xanthine Oxidase Inhibitor
Pharmacy Times: Study: Gout Flare Ups Can Lead to Four-Times Higher Risk of Heart Attack, Stroke
New Life Outlook: Gout and Eye Problems
Health Central: Gout Myths—Busted
Healthline: How Gout Flare-ups May Increase the Risk of Heart Attack, Stroke
Physicians Weekly: Urate-Lowering Treatments Compared for Gout
Arthritis & Rheumatology: Superiority of Low-Dose Benzbromarone to Low-Dose Febuxostat in a Prospective, Randomized Comparative Effectiveness Trial in Gout Patients With Renal Uric Acid Underexcretion
Healio.com: 'Horribly mismanaged': Debate over gout treatment rages as cases surge
Gout and Heart Disease: Why You're at Increased Risk
Physicians Weekly: Analyzing the Genetics of Hyperuricemia & Gout in Post-Partum Racial/Ethnic Groups